US 9220692
Methods of reducing symptoms in subjects using single dosage forms with tapering release rates
granted A61KA61K31/00A61K31/137
Quick answer
US patent 9220692 (Methods of reducing symptoms in subjects using single dosage forms with tapering release rates) held by TEVA WOMEN'S HEALTH, INC. expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA WOMEN'S HEALTH, INC.
- Grant date
- Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/00, A61K31/137, A61K31/465, A61K31/515